CNBX (CNBX Pharmaceuticals) Days Payable : 0.00 (As of Nov. 2024)

View and export this data going back to 2007. Start your Free Trial

What is CNBX Pharmaceuticals Days Payable?

CNBX Pharmaceuticals's average Accounts Payable for the three months ended in Nov. 2024 was $0.05 Mil. CNBX Pharmaceuticals's Cost of Goods Sold for the three months ended in Nov. 2024 was $0.00 Mil.

The historical rank and industry rank for CNBX Pharmaceuticals's Days Payable or its related term are showing as below:

CNBX' s Days Payable Range Over the Past 10 Years
Min: 0 Med: 0 Max: 7925.71
Current: 7925.71

During the past 13 years, CNBX Pharmaceuticals's highest Days Payable was 7925.71. The lowest was 0.00. And the median was 0.00.

CNBX's Days Payable is ranked better than
95.74% of 705 companies
in the Biotechnology industry
Industry Median: 122.08 vs CNBX: 7925.71

CNBX Pharmaceuticals's Days Payable stayed the same from Nov. 2023 (0.00) to Nov. 2024 (0.00). stayed the same

CNBX Pharmaceuticals Days Payable Historical Data

The historical data trend for CNBX Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CNBX Pharmaceuticals Days Payable Chart

CNBX Pharmaceuticals Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Aug24

Days Payable

Get a 7-Day Free Trial

CNBX Pharmaceuticals Quarterly Data
	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24
Days Payable	Get a 7-Day Free Trial															-	3,109.02	-	-	-

Competitive Comparison of CNBX Pharmaceuticals's Days Payable

For the Biotechnology subindustry, CNBX Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CNBX Pharmaceuticals's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CNBX Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where CNBX Pharmaceuticals's Days Payable falls into.

CNBX Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

CNBX Pharmaceuticals's Days Payable for the fiscal year that ended in Aug. 2024 is calculated as

	Days Payable (A: Aug. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Aug. 2023 )	+	Accounts Payable (A: Aug. 2024 ))	/	count )	/	Cost of Goods Sold (A: Aug. 2024 )	*	Days in Period
=	( (0.336	+	0.041)	/	2 )	/	0	*	365
=	0.1885					/	0	*	365
=	N/A

CNBX Pharmaceuticals's Days Payable for the quarter that ended in Nov. 2024 is calculated as:

	Days Payable (Q: Nov. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Aug. 2024 )	+	Accounts Payable (Q: Nov. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Nov. 2024 )	*	Days in Period
=	( (0.041	+	0.052)	/	2 )	/	0	*	365 / 4
=	0.0465					/	0	*	365 / 4
=	N/A

CNBX Pharmaceuticals Days Payable Related Terms

Thank you for viewing the detailed overview of CNBX Pharmaceuticals's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

CNBX Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CNBX Pharmaceuticals Inc (OTCPK:CNBX) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3 Bethesda Metro Center, Suite 700, Bethesda, MD, USA, 20814

Website

https://www.cnbxpharma.com

CNBX Pharmaceuticals Inc is a clinical-stage biotechnology company. It develops pharmaceuticals focusing on cancer research utilizing HTS technology and personalized bioinformatics tools. The company's main focus is the development of cannabinoid therapies and other technologies for the treatment of cancer, mainly cancers of the gastrointestinal tract, skin, breast, and prostate. The firm's main product is the Cannabics SR, an oral capsule developed for the treatment of patients with cancer and cancer anorexia cachexia syndrome (CACS). It also has an anti-neoplastic drug candidate under development for Colorectal Cancer (CRC) named RCC-33.

Executives

Cannabics Inc.	10 percent owner	108 WEST 13TH ST., WILMINGTON DE 19801
Thomas E Mills	director, officer: President, CEO, CFO
North American Mining Corp	10 percent owner	6767 WEST TROPICANA AVENUE, SUITE 229, LAS VEGAS NV 89103
Lou Hilford	director, officer: Vice-President, Secretary